NUTRA PHARMA CORP (NPHC) › Shareholders' EquityNUTRA PHARMA CORP (NPHC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: -$2.56M2009: -$1.14M2010: -$2.31M2011: -$3.91M2012: -$3.58M2013: -$4.22M2014: -$3.59M2015: -$3.57M2016: -$4.48M2017: -$5.41M2018: -$5.94M2019: -$11.70M2020: -$11.49M2021: -$20.88M2022: -$12.38M2023: -$13.77M2024: -$14.81M2025: -$16.83M-$16.83M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$16.83M-13.6%2024-$14.81M-7.6%2023-$13.77M-11.2%2022-$12.38M+40.7%2021-$20.88M-81.6%2020-$11.49M+1.8%2019-$11.70M-97.1%2018-$5.94M-9.7%2017-$5.41M-20.8%2016-$4.48M-25.2%2015-$3.57M+0.6%2014-$3.59M+14.8%2013-$4.22M-18.0%2012-$3.58M+8.6%2011-$3.91M-69.0%2010-$2.31M-102.2%2009-$1.14M+55.2%2008-$2.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share